Insider · CIK 0001554353
Lawrence P. Guiheen
Files at ADMA (ADMA BIOLOGICS, INC.). First filing May 23, 2025, latest Jun 11, 2025.
In brief
Lawrence P. Guiheen files SEC Form 4 as director at ADMA (ADMA BIOLOGICS, INC.). Since May 23, 2025, Lawrence P. Guiheen has reported 0 open-market buys worth $0 and 2 open-market sells worth $602k, the latest filed on Jun 11, 2025.
A track record needs three past buys with six months of prices behind them; Lawrence P. Guiheen has 0, so none is measured yet.
The newest scored trade: sold $419k of ADMA on Jun 9, 2025, filed Jun 11, 2025, scored 51 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ADMA: ADMA BIOLOGICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | ADMA BIOLOGICS, INC. | $419k 20,000 shares | -17% | +35% from low-15% from high | |
| 20Weak | ADMA BIOLOGICS, INC. | $183k 9,000 shares | -7% | +30% from low-18% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 4, 2025 | ADMA ADMA BIOLOGICS INC | 20,000 0.01% of outstanding | $415k | Jun 4, 2025 | none |
| May 21, 2025 | ADMA ADMA BIOLOGICS, INC. | 9,000 0.00% of outstanding | $184k | May 21, 2025 | none |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +30,000 | $3.66 | $110k | 135,520 | Mar 17, 2026 |
| Mar 17, 2026 | ADMA ADMA BIOLOGICS, INC. | GGift Common Stock | -30,000 | $0.00 | $0 | 105,520 | Mar 17, 2026 |
| Mar 17, 2026 | ADMA ADMA BIOLOGICS, INC. | GGift Common Stockindirect: See footnote | +30,000 | $0.00 | $0 | 30,000 | Mar 17, 2026 |
| Mar 13, 2026 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 23,837 | Mar 17, 2026 |
| Feb 9, 2026 | ADMA ADMA BIOLOGICS, INC. | AGrant or award Common Stock | +10,690 | $0.00 | $0 | 105,520 | Feb 11, 2026 |
| Feb 9, 2026 | ADMA ADMA BIOLOGICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +17,730 | $0.00 | $0 | 17,730 | Feb 11, 2026 |
| Jun 9, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock | -20,000 | $20.96 | $419k | 94,830 | Jun 11, 2025 |
| May 21, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +7,779 | $5.96 | $46k | 122,609 | May 23, 2025 |
| May 21, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock | -7,779 | $20.32 | $158k | 114,830 | May 23, 2025 |
| May 22, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +1,221 | $5.96 | $7,277 | 116,051 | May 23, 2025 |
| May 22, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock | -1,221 | $20.12 | $25k | 114,830 | May 23, 2025 |
| May 21, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative | -7,779 | $0.00 | $0 | 1,221 | May 23, 2025 |
| May 22, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (right to buy)derivative | -1,221 | $0.00 | $0 | 0 | May 23, 2025 |
| Feb 19, 2025 | ADMA ADMA BIOLOGICS, INC. | AGrant or award Common Stock | +10,889 | $0.00 | $0 | 164,830 | Feb 21, 2025 |
| Feb 19, 2025 | ADMA ADMA BIOLOGICS, INC. | AGrant or award Stock Option (right to buy)derivative | +16,279 | $0.00 | $0 | 16,279 | Feb 21, 2025 |
Questions about Lawrence P. Guiheen
Answered from the filings on this page, as of the latest one.
Is Lawrence P. Guiheen buying or selling?
Not in the last 12 months. Lawrence P. Guiheen's latest open-market trade on SEC Form 4 was sold $419k of ADMA on Jun 9, 2025.
How did Lawrence P. Guiheen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lawrence P. Guiheen has 0.
Where does Lawrence P. Guiheen file Form 4?
Lawrence P. Guiheen has filed Form 4 at ADMA (ADMA BIOLOGICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.